To amend title XIX to extend protection for Medicaid recipients of home and community-based services against spousal impoverishment, establish a State Medicaid option to provide coordinated care to children with complex medical conditions through health homes, prevent the misclassification of drugs for purposes of the Medicaid drug rebate program, and for other purposes.
Medicaid Services Investment and Accountability Act of 2019
This bill alters several Medicaid programs and funding provisions.
(Sec. 2) The bill temporarily extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home- and community-based services.
(Sec. 3) The bill also establishes a state Medicaid option to provide for medical assistance with respect to coordinated care provided through a health home (i.e., a designated provider or team of health-care professionals) for children with medically complex conditions. States must determine payment methodologies in accordance with specified requirements; payments also temporarily qualify for an enhanced federal matching rate.
(Sec. 4) The bill also temporarily extends the Medicaid demonstration program for certified community behavioral health clinics.
(Sec. 5) The bill increases funding available to the Money Follows the Person Rebalancing Demonstration Program. (Under this program, the Centers for Medicare & Medicaid Services may award grants to state Medicaid programs to assist states in increasing the use of home and community care for long-term care and decreasing the use of institutional care.)
(Sec. 6) Further, drug manufacturers with Medicaid rebate agreements for covered outpatient drugs must disclose drug product information. Manufacturers are subject to civil penalties for knowingly misclassifying drugs. Manufacturers are also required to compensate for rebates that were initially underpaid as a result of misclassification (whether or not such misclassification was committed knowingly).
Read twice and referred to the Committee on Finance.
Read twice and referred to the Committee on Finance.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Mr. Ruiz moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H2773-2780)
DEBATE - The House proceeded with forty minutes of debate on H.R. 1839.
At the conclusion of debate, the chair put the question on the motion to suspend the rules. Mr. Burgess objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was considered as withdrawn.
Considered as unfinished business. (consideration: CR H2781)
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H2773-2776)
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H2773-2776)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate, read twice.
Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.(consideration: CR S2203)
Enacted as Public Law 116-16
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line
Passed Senate without amendment by Voice Vote. (consideration: CR S2203)
Message on Senate action sent to the House.
Sponsor introductory remarks on measure. (CR H3224)
Presented to President.
Presented to President.
Signed by President.
Signed by President.
Became Public Law No: 116-16.
Became Public Law No: 116-16.